Healthy Aging, Changes in Body Composition, and Therapeutic Approaches to Reverse Age-Related Hormonal and Physical Decline
Adil Abbasi, MD FACP FACN
Learning Objectives
After completing this chapter, the reader should be able to:
Introduction
Aging is a complex biological process characterized by progressive declines in physiological reserve, body composition, endocrine function, and regenerative capacity. While aging is inevitable, the rate and severity of age-related decline vary considerably among individuals and are strongly influenced by genetics, nutrition, physical activity, sleep, chronic disease burden, and environmental exposures.
Healthy aging refers to maintaining functional independence, cognitive health, physical strength, metabolic health, and quality of life despite advancing age. Modern geroscience increasingly focuses on extending "health span" rather than merely prolonging lifespan.
One of the most visible manifestations of aging is the progressive alteration in body composition. Beginning as early as the fourth decade of life, adults gradually lose skeletal muscle mass and strength while accumulating visceral adiposity. Simultaneously, endocrine changes including reductions in testosterone, growth hormone, insulin-like growth factor-1 (IGF-1), dehydroepiandrosterone (DHEA), and estrogen contribute to further declines in muscle mass, bone density, metabolic function, and physical performance.
Changes in Body Composition with Aging
Sarcopenia: Sarcopenia refers to the progressive loss of skeletal muscle mass, strength, and physical performance associated with aging. Muscle mass declines approximately 3–8% per decade after age 30 and accelerates after age 60. Muscle strength declines even faster than muscle mass, contributing significantly to disability and frailty. Mechanisms include:
Clinically, sarcopenia leads to:
Increase in Fat Mass: Aging is associated with:
Visceral fat accumulation promotes:
Visceral adiposity is one of the strongest predictors of adverse health outcomes in older adults.
Bone Loss: Bone mineral density declines progressively with age. Consequences include:
The combination of osteoporosis and sarcopenia ("osteosarcopenia") markedly increases morbidity and mortality.
Hormonal Changes with Aging: Several endocrine systems undergo gradual decline.
Testosterone: Total and free testosterone levels decrease progressively with age. Free testosterone declines more rapidly because sex hormone-binding globulin (SHBG) increases with aging. Consequences include:
Age-related testosterone decline has been strongly associated with sarcopenia and frailty.
Growth Hormone and IGF-1: Growth hormone secretion declines dramatically with age, a process sometimes referred to as "somatopause."
By age 70:
Effects include:
Dehydroepiandrosterone (DHEA): DHEA levels decline approximately 80–90% between ages 20 and 80. Potential effects include:
The clinical significance remains incompletely understood.
Estrogen: In women, menopause results in abrupt estrogen deficiency leading to:
Mechanisms of Age-Related Body Composition Changes: Multiple interconnected mechanisms contribute:
Anabolic Resistance: Older muscle becomes less responsive to:
Higher protein intake is therefore required to stimulate muscle protein synthesis.
Chronic Inflammation: Aging is associated with elevated:
This phenomenon ("inflammaging") promotes catabolism and muscle loss.
Mitochondrial Dysfunction: Declining mitochondrial function reduces:
Insulin Resistance: Insulin resistance impairs nutrient utilization and contributes to:
Lifestyle Approaches to Reverse Body Composition Changes
Resistance Training: Resistance exercise is the most effective intervention for age-related muscle loss.
Benefits include:
Most studies demonstrate measurable gains even in adults over age 80.
Recommended:
Resistance training remains the single most powerful anti-sarcopenia intervention available.
Protein Optimization: Current evidence suggests older adults require higher protein intake than younger adults.
Current Recommendations:
Protein should be distributed throughout the day with emphasis on leucine-rich sources.
Weight Reduction with Muscle Preservation: In obese older adults:
can reduce visceral fat while preserving lean body mass and rapid weight loss without exercise accelerates sarcopenia.
Sleep Optimization: Poor sleep is associated with:
Seven to nine hours of quality sleep remains an important component of healthy aging.
Testosterone Replacement Therapy in Older Adults
Physiological Rationale: Testosterone is a major anabolic hormone regulating:
Declining testosterone contributes significantly to age-related body composition changes.
Effects on Body Composition: Multiple randomized trials demonstrate that testosterone replacement in hypogonadal men:
Average gains in lean mass are typically 1–3 kg over 6–12 months.
Some studies also demonstrate improvements in muscle strength and physical performance, although findings are not universally consistent.
Guideline Recommendations: Current endocrine guidelines recommend testosterone therapy only for men with:
Routine testosterone administration solely to counter normal aging is not recommended.
Potential Benefits
Sexual Health
Body Composition
Bone Health
Hematologic Effects
Quality of Life
Risks and Monitoring: Potential adverse effects include:
Monitoring should include:
Modern evidence suggests cardiovascular risk is likely neutral when therapy is appropriately prescribed and monitored per guidelines documented above.
Growth Hormone (GH) Therapy in Older Adults
Physiological Rationale: Growth hormone (GH) stimulates:
Because GH secretion declines substantially with age, GH replacement has long been proposed as an anti-aging therapy.
Effects on Body Composition: Clinical studies demonstrate that GH replacement:
Some studies combining GH and testosterone showed greater improvements in body composition than either intervention alone.
Limitations: Despite favorable changes in body composition:
Importantly, increased muscle mass does not always translate into increased muscle strength.
Adverse Effects: GH therapy may cause:
Because of these concerns, routine GH therapy for healthy older adults is generally not recommended. Most professional societies do not endorse GH as an anti-aging treatment.
Emerging Therapies: Several novel approaches are under investigation:
Growth Hormone Secretagogues
Examples:
These agents increase endogenous GH release but remain investigational.
Selective Androgen Receptor Modulators (SARMs)
Designed to provide anabolic benefits with fewer androgenic adverse effects.
Currently not approved for routine clinical use.
Myostatin Inhibitors
Potential future therapies that may significantly enhance muscle growth.
Senolytics
Experimental therapies targeting cellular senescence to improve healthspan.
Practical Clinical Approach
The foundation of healthy aging remains:
Hormonal therapies should be considered adjunctive rather than primary interventions. For older men with documented hypogonadism and symptoms, testosterone replacement may offer meaningful improvements in body composition, sexual function, bone density, and quality of life when appropriately monitored. Growth hormone therapy, despite favorable body composition effects, currently lacks sufficient evidence to support routine use in healthy aging populations.
Anti-Aging and Rejuvenation Clinics: Evidence-Based Interventions, Emerging Therapies, and Clinical Controversies.
Adil Abbasi, MD FACP FACN
Evidence-supported, when medically indicated
Reasonable / legitimate:
Research-supported but not routine anti-aging care
Growth hormone: GH can improve body composition in true adult GH deficiency, but it is not FDA-approved for anti-aging and is generally not recommended for otherwise healthy older adults. Risks include edema, arthralgia, carpal tunnel symptoms, insulin resistance, and hyperglycemia.
DHEA, peptides, GH secretagogues, NAD infusions, “mitochondrial” IVs: biologically interesting, but clinical outcome evidence for meaningful rejuvenation, frailty reversal, cognitive benefit, or longevity is limited or inconsistent.
High-risk marketing - often quackery
Be very skeptical of clinics selling:
The FDA states there are no FDA-approved exosome products and warns that unapproved regenerative products, including stem cells and exosomes, have been associated with serious harms such as infections, blindness, and tumor formation.
Practical conclusion
A good clinic should look like preventive medicine + endocrinology + exercise physiology, not a sales center. True healthy-aging care is evidence-based risk reduction and functional preservation. “Rejuvenation therapy” becomes quackery when it sells hormones, peptides, stem cells, or IV infusions to people without a clear diagnosis, measurable endpoint, informed consent, and safety monitoring.
Best test: ask, “What randomized controlled trials show this improves falls, fractures, diabetes, cardiovascular events, cognition, disability, or mortality in people like me?” If the answer is vague, it is marketing.
Cautions for Clinicians and Patients Regarding Anti-Aging, Rejuvenation, and Longevity Clinics: The rapid growth of anti-aging, rejuvenation, wellness, regenerative medicine, and longevity clinics reflects a genuine desire among patients to maintain health, function, vitality, and independence as they age. While some clinics provide evidence-based preventive and hormonal care, others market expensive interventions with limited scientific support, exaggerated claims, and inadequate safety monitoring.
Both clinicians and patients should approach these services with careful scrutiny.
Why Patients Are Vulnerable: Aging is often associated with:
These concerns are real and deserve attention. Unfortunately, they also create a fertile environment for marketing strategies that promise:
Such claims frequently exceed the available scientific evidence.
Common Red Flags
1. Universal Hormone Deficiency Diagnoses: A major warning sign is a clinic that appears to diagnose nearly every patient with:
True endocrine deficiencies exist, but not every age-related symptom reflects a hormone related deficiency. Normal aging should not automatically be medicalized.
2. Treatment Before Proper Evaluation: Patients should be concerned if treatment is recommended before:
Fatigue, weight gain, poor libido, and reduced energy may result from:
These conditions require proper diagnosis rather than immediate hormone administration.
3. Claims of "Age Reversal": There is currently no scientifically validated intervention proven to:
While certain interventions improve biomarkers and physical function, claims of dramatic age reversal should be viewed skeptically.
4. Stem Cell and Exosome Marketing: One of the fastest-growing areas of concern involves:
Many clinics advertise these products as treatments for:
Current evidence does not support many of these broad claims.
The FDA has repeatedly warned against unapproved regenerative medicine products marketed directly to consumers.
5. Growth Hormone as an Anti-Aging Treatment: Growth hormone remains one of the most heavily marketed anti-aging therapies. Research demonstrates:
However:
Potential complications include:
Most endocrine societies do not recommend growth hormone solely for anti-aging purposes.
6. Expensive Intravenous Wellness Programs: Many clinics offer:
Although deficiencies should be corrected, robust evidence supporting routine IV administration for healthy individuals remains limited. Many benefits reported by patients may reflect:
rather than durable physiological change.
Potential Risks to Patients
Cardiovascular Complications: Improper hormone use may increase risk of:
particularly when monitoring is inadequate.
Missed Diagnoses: A focus on "hormone optimization" may delay diagnosis of:
The underlying disease may progress while symptoms are attributed to "aging."
Financial Exploitation: Many anti-aging clinics operate on cash-pay models. Patients may spend:
without proven long-term benefit.
A large financial commitment should demand equally strong scientific evidence.
Psychological Dependence: Some patients develop dependence on repeated testing, supplements, injections, and treatments. This may create:
Recommendations for Clinicians: Clinicians should:
Maintain Scientific Skepticism: Demand evidence from:
rather than marketing materials.
Focus on Functional Outcomes: The key questions are:
Changes in laboratory values alone are insufficient.
Evaluate Root Causes: Symptoms attributed to aging may reflect:
These likely causes should be addressed and investigated first.
Use Hormones Appropriately: When prescribing testosterone or other hormones:
Recommendations for Patients: Before beginning any rejuvenation program, patients should ask:
What is the diagnosis? A treatment should address a clearly defined medical condition.
What evidence supports this treatment? Ask specifically:
What are the risks? Every effective treatment has potential adverse effects. If a clinic claims a therapy is completely safe, skepticism is warranted.
How will success be measured? Meaningful outcomes include:
rather than simply changing laboratory numbers.
Is the treatment approved? Patients should understand whether:
What Truly Works for Healthy Aging? The strongest evidence continues to support:
These interventions consistently outperform most marketed anti-aging therapies in improving health span, functional status, and longevity.
Bottom Line: Not all rejuvenation or longevity clinics are fraudulent. Some provide legitimate preventive care, hormone replacement for documented deficiencies, nutrition counseling, and exercise optimization. However, the field is also populated by businesses that market expensive interventions with limited evidence and exaggerated claims.
The hallmark of a reputable program is not how many treatments it sells, but how rigorously it applies scientific evidence, individualizes care, monitors safety, and prioritizes proven strategies that improve health, function, and quality of life.
For both clinicians and patients, the guiding principle should remain:
"Extraordinary claims require extraordinary evidence."
In healthy aging medicine, the most effective interventions are often the least glamorous: exercise, nutrition, sleep, disease prevention, and evidence-based medical care. These remain the true foundation of successful aging.
____________________________________________________________________________
Summary
References
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.
Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, et al. (2002). Growth hormone and sex steroid administration in healthy aged women and men: A randomized controlled trial. JAMA, 288(18), 2282–2292.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31.
Grossmann M, Matsumoto AM. (2023). A perspective on middle-aged and older men with functional hypogonadism: Focus on holistic management. Journal of Clinical Endocrinology & Metabolism, 108(9), e871–e889.
Morley JE. (2016). Frailty and sarcopenia in older persons. Clinical Geriatric Medicine, 32(2), 201–214.
Sattler FR, Castaneda-Sceppa C, Binder EF, Schrager M, Wang Y, Bhasin S, et al. (2009). Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology & Metabolism, 94(6), 1991–2001.
Shin MJ, Jeon YK, Kim IJ. (2018). Testosterone and sarcopenia. World Journal of Men's Health, 36(3), 192–198.
Stanworth RD, Jones TH. (2008). Testosterone for the aging male: Current evidence and recommended practice. Clinical Interventions in Aging, 3(1), 25–44.
Urban RJ. (2014). Translational studies in older men using testosterone to treat sarcopenia. Current Aging Science, 7(2), 114–121.
Vermeulen A. (1999). Testosterone, body composition and aging. Journal of Endocrinological Investigation, 22(Suppl 5), 110–116.
Volpi E, Nazemi R, Fujita S. (2004). Muscle tissue changes with aging. Current Opinion in Clinical Nutrition and Metabolic Care, 7(4), 405–410.
Yabluchanskiy A, Tsitlakidou D, et al. (2019). Is testosterone replacement therapy in older men effective and safe? Drugs & Aging, 36(7), 593–601.
de Velasco LMC, et al. (2025). Testosterone replacement therapy in men aged 50 years and above: Effects on body composition and health outcomes. Clinical Interventions in Aging, 20, 125–140.
Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, et al. (2007). Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 146(2), 104–115.
Meldrum DR, Morris MA, Gambone JC. (2013). Obesity pandemic: Causes, consequences, and solutions—but do we have the will? Fertility and Sterility, 99(4), 833–839.
Kirkland JL, Tchkonia T. (2020). Senolytic drugs: From discovery to translation. Journal of Internal Medicine, 288(5), 518–536.
FDA Center for Biologics Evaluation and Research. (2024). Consumer alert on regenerative medicine products including stem cells and exosomes. U.S. Food and Drug Administration.
National Institute on Aging. (2024). Exercise and physical activity for older adults. National Institutes of Health.
American College of Sports Medicine. (2023). ACSM Position Stand: Resistance exercise for older adults. Medicine & Science in Sports & Exercise.
Bhasin S, Lincoff AM, Basaria S, et al. (2023). Cardiovascular safety of testosterone replacement therapy in middle-aged and older men with hypogonadism. New England Journal of Medicine, 389, 107–117.
LeBrasseur NK, Walsh K, Arany Z. (2015). Metabolic benefits of resistance training and exercise in aging populations. Cell Metabolism, 22(1), 11–21.
Ferrucci L, Fabbri E. (2018). Inflammaging: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nature Reviews Cardiology, 15(9), 505–522.
Rosen CJ, et al. (2012). Growth hormone and aging: Clinical implications and current controversies. Endocrine Reviews, 33(3), 346–370.